SPL 0.00% 9.9¢ starpharma holdings limited

Could we pleasantly be surprised at AGM, page-6

  1. WBA
    2,344 Posts.
    lightbulb Created with Sketch. 416
    June 2014, when he was first appointed,
    5SP 53c
    DEP doctexal phase 1 commenced
    phase 3 vivagel two trials commenced
    24m cash
    10m annual burn

    9 years later
    SP 13c
    no dep phase 2 results
    no vivagel approval in largest market
    35m cash
    13.5m annual burn
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.